(Q28142282)

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900087-8

A study of the desensitization produced by acetylcholine at the motor end-plate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900087-8

The Energy Landscapes and Motions of Proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900087-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900087-8

Transduction is a major factor influencing receptor characterization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900087-8

On the importance of the "antagonist assumption" to how receptors express themselves.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900087-8

Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900087-8

Challenges for receptor theory as a tool for drug and drug receptor classification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900087-8

Receptor Occupancy and Tissue Response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900087-8

Extended concentration-response curves used to reflect full agonist efficacies and receptor occupancy-response coupling ranges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900087-8

A model of two functionally antagonistic receptor populations activated by the same agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900087-8

Lower efficacy: interaction with an inhibitory receptor or partial agonism?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900087-8

Models to explain dose-response relationships that exhibit a downturn phase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900087-8

The quantification of relative efficacy of agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900087-8

An operational model of pharmacological agonism: the effect of E/[A] curve shape on agonist dissociation constant estimation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900087-8

Estimation of agonist affinity and efficacy by direct, operational model-fitting.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900087-8

Determination of the functional dissociation constant of a partial agonist by comparison with a higher efficacy agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900087-8

Errors in agonist affinity estimation: do they and should they occur in isolated tissue experiments?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900087-8

To what extent can binding studies allow the quantification of affinity and efficacy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900087-8

Rethinking receptor-G protein-effector interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900087-8

Seven helix receptors are enzymes catalysing G protein activation. What is the agonist Kact?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900087-8

Modulation of agonist binding by guanine nucleotides in CHO cells expressing muscarinic m1-m5 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900087-8

Structure and function of G protein coupled receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900087-8

In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900087-8

Structure and function of G protein-coupled receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900087-8

Constitutively active G protein-coupled receptors: potential mechanisms of receptor activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900087-8

Constitutive activation of muscarinic receptors by the G-protein Gq.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900087-8

Regions of the alpha 1-adrenergic receptor involved in coupling to phosphatidylinositol hydrolysis and enhanced sensitivity of biological function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900087-8

Agonist-receptor efficacy. II. Agonist trafficking of receptor signals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900087-8

Agonist-receptor efficacy. I: Mechanisms of efficacy and receptor promiscuity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900087-8

Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900087-8

Antagonists with negative intrinsic activity at delta opioid receptors coupled to GTP-binding proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900087-8

Labelling of recombinant human and native rat serotonin 5-HT1A receptors by a novel, selective radioligand, [3H]-S 15535: definition of its binding profile using agonists, antagonists and inverse agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900087-8

Reciprocal modulation of agonist and antagonist binding to muscarinic cholinergic receptor by guanine nucleotide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900087-8

Fluorescent labeling of purified beta 2 adrenergic receptor. Evidence for ligand-specific conformational changes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900087-8

Structural instability of a constitutively active G protein-coupled receptor. Agonist-independent activation due to conformational flexibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900087-8

Molecular mechanisms of membrane receptor desensitization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900087-8

beta2-adrenergic receptor desensitization, internalization, and phosphorylation in response to full and partial agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900087-8

In vitro down-regulation predicts agonist efficacy at central muscarinic cholinergic receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900087-8

A constitutively active mutant beta 2-adrenergic receptor is constitutively desensitized and phosphorylated

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900087-8

Agonist efficacy and allosteric models of receptor action.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900087-8

The relationship between agonist intrinsic activity and the rate of endocytosis of muscarinic receptors in a human neuroblastoma cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900087-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-2952(99)00087-8

0 references

Fatcat ID

release_7vkevpbw6nfzrfltm4p6fa27oq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7vkevpbw6nfzrfltm4p6fa27oq